Kinase inhibitor with improved solubility profile
    10.
    发明授权
    Kinase inhibitor with improved solubility profile 有权
    具有改善溶解度特征的激酶抑制剂

    公开(公告)号:US08436179B2

    公开(公告)日:2013-05-07

    申请号:US13551680

    申请日:2012-07-18

    IPC分类号: C07D513/02 A61K31/44

    CPC分类号: C07D495/04

    摘要: 4-Amino-N-[3-(diethylamino)propyl]-3-(4-{[(3-fluorophenyl)carbamoyl]amino}phenyl)thieno[3,2-c]pyridine-7-carboxamide which inhibits protein kinases such as Aurora-kinases and the VEGFR and PDGFR families of kinases, with an improved aqueous solubility profile, compositions containing 4-amino-N-[3-(diethylamino)propyl]-3-(4-{[(3-fluorophenyl)carbamoyl]amino}phenyl)thieno[3,2-c]pyridine-7-carboxamide and methods of treating diseases using 4-amino-N-[3-(diethylamino)propyl]-3-(4-{[(3-fluorophenyl)carbamoyl]amino}phenyl)thieno[3,2-c]pyridine-7-carboxamide are disclosed.

    摘要翻译: 噻吩并[3,2-c]吡啶-7-甲酰胺(其抑制蛋白激酶)的4-氨基-N- [3-(二乙基氨基)丙基] -3-(4 - {[(3-氟苯基)氨基甲酰基]氨基}苯基) 例如Aurora激酶和具有改善的水溶性曲线的激酶的VEGFR和PDGFR家族,含有4-氨基-N- [3-(二乙基氨基)丙基] -3-(4 - {[(3-氟苯基) 氨基甲酰基]氨基}苯基)噻吩并[3,2-c]吡啶-7-甲酰胺的方法和使用4-氨基-N- [3-(二乙基氨基)丙基] -3-(4 - {[ 氟苯基)氨基甲酰基]氨基}苯基)噻吩并[3,2-c]吡啶-7-甲酰胺。